SVE Synthaverse S.A.

0.6638USD2.670 PLN · GPW0.00%Mkt Cap: 50.46M USDP/E: —

Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents for use in oncology, gynecology, hematology, immunology, and related therapeutic areas i…

Key Statistics

Company
Market Cap50.46M USD
Enterprise Value71.07M USD
Revenue (TTM)12.12M USD
Gross Profit5.86M USD
Net Income (TTM)-4.96M USD
Revenue/Share0.16 USD
Last Price0.6638 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees214
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLBMDLB00018
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-32.82
EV/Revenue5.86
P/S4.16
P/B1.70
EPS (TTM)-0.07 USD
EPS (Forward)—
52W Range
0.609112% of range1.055
52W High1.055 USD
52W Low0.6091 USD
Profitability
Gross Margin56.09%
Oper. Margin-34.02%
EBITDA Margin-17.86%
Profit Margin-47.45%
ROE-15.99%
ROA-6.55%
ROIC-5.24%
ROCE-7.72%
Growth
Revenue Growth104.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.94M USD
CapEx (TTM)6.97M USD
FCF Margin-122.63%
FCF Yield-29.46%
Net Debt20.61M USD
Net Debt/EBITDA-9.52
Net Debt/FCF—
Balance Sheet
Debt/Equity0.68
Current Ratio0.87
Quick Ratio0.16
Book Value/Sh0.39 USD
Cash/Share0.0012 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.76.02M
Float48.61M
Insiders43.87%
Institutions6.83%
Technical
SMA 500.6910 (-3.9%)
SMA 2000.7682 (-13.6%)
Beta-0.07
S&P 52W Chg12.00%
Avg Vol (30d)49.89K
Avg Vol (10d)70.94K
Technical Indicators
RSI (14)47.2
MACD-0.0262
MACD Signal-0.0408
MACD Hist.+0.0146
BB Upper0.6981 USD
BB Middle0.6625 USD
BB Lower0.6268 USD
BB Width10.77%
ATR (14)0.0239 USD
Vol Ratio (20d)0.66x

About Synthaverse (WSE: SVE)

›

Synthaverse (WSE: SVE) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 214 employees.

The shares were at 2.670 PLN on 19 November 2026, down 35.5% over 52 weeks. Its 52-week range is 2.450 PLN to 4.245 PLN: the price is 37.1% below the high and 9.0% above the low.

Its market capitalisation is 202.97M PLN.

Synthaverse reports return on equity of -16.0%, an operating margin of -34.0% and revenue up 104.5% year over year.

Its debt exceeds its cash by 82.91M PLN, a debt-to-equity ratio of 0.68. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.